1027065-32-2

Upstream product

• 39499-57-5 4H,5H-6-phenoxyphenylpyridazin-3(2H)-one 
• 36330-86-6 4-oxo-4-(4-phenoxyphenyl)butanoic acid 
• 101-84-8 diphenylether 
• 1105194-70-4 C₁₆H₁₁ClN₂O 

Downstream Products

• 1262619-36-2 3,3,3-trifluoro-N'-(6-(4-phenoxyphenyl)pyridazin-3-yl)propanehydrazide 
• 1268133-88-5 3-phenyl-6-(4'-phenoxyphenyl)-1,2,4-triazolo[4,3-b]pyridazine 
• 1268133-90-9 3-(4'-tolyl)-6-(4'-phenoxyphenyl)-1,2,4-triazolo[4,3-b]pyridazine 

Relevant academic research and scientific papers

FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS

The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein W1, W2, W3, R1, Q, X1, X2 and X3 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.